Promote neural cell growth to address neurological diseases and cognitive dysfunction.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Bolden Therapeutics is a biotechnology company developing novel therapeutics that aim to stimulate the formation of new neurons in the adult brain to address neurological conditions. Its research focuses on leveraging molecular targets and antisense oligonucleotides to increase neurogenesis with the goal of improving cognitive function in central nervous system diseases. The company’s work is centered on advancing potential treatments that could benefit people affected by neurodegenerative and cognitive disorders.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Bolden Therapeutics Management Team
Bolden Therapeutics Valuations & Financials
View real-time NPM data on Bolden Therapeutics stock including daily Bolden Therapeutics stock price estimates, valuation history, and historical share price information. Access Bolden Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Bolden Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Bolden Therapeutics? Get in touch to learn more.
Similar Companies
like Bolden Therapeutics
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Ego
Media & Entertainment
Spawns AI characters which live in and move across interactive worlds with memory and agency.
InterVenn
Healthcare & Life Sciences
Delivers artificial intelligence-driven glycoproteomic analysis to accelerate early disease detection and clinical biomarker discovery for personalized medicine.
11x
AI & Machine Learning
Builds autonomous digital workers that execute sales and revenue workflows with minimal human input.
Halio
Climate & Sustainability
Develops smart-tinting glass that adapts to light, improving indoor comfort, energy efficiency, and daylight management in buildings.
Spinwheel
FinTech
Provides a platform that helps users manage, pay down, and optimize debt by integrating automated solutions into partner apps and services.
MyCarrier
Commerce & Marketplaces
Digital freight platform connecting shippers with carriers for streamlined logistics, offering rate comparison, dispatching, and tracking services.
Unspun
Industrials
Develops 3D weaving technology for fast, local, low-waste, on-demand apparel production by weaving yarn directly into finished garments.
FAQ
We have answers
Bolden Therapeutics stock does not trade on public stock exchanges. Bolden Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Bolden Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Bolden Therapeutics Stock does not trade on public stock exchanges. In order to sell Bolden Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Bolden Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Bolden Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Bolden Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Bolden Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Bolden Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Bolden Therapeutics is a private company and has not had an IPO. There is currently no Bolden Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Bolden Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
